(2021) Activation of mTORC1 at late endosomes misdirects T cell fate determination in older individuals. Sci ImmunolEven though the new era of mTOR inhibitors keep wonderful guarantee for anticancer therapy and are promptly transferring into clinical trials, there are numerous vital concerns that decide their accomplishment while in the clinic. For